In the BioHarmony Drug Report Database

"Preview" Icon

Diethylcarbamazine

Hetrazan (diethylcarbamazine) is a small molecule pharmaceutical. Diethylcarbamazine was first approved as Hetrazan on 1982-01-01. It is used to treat filarial elephantiasis, loiasis, and pulmonary eosinophilia in the USA.

 

Trade Name

 

Hetrazan
 

Common Name

 

diethylcarbamazine
 

ChEMBL ID

 

CHEMBL684
 

Indication

 

filarial elephantiasis, loiasis, pulmonary eosinophilia
 

Drug Class

 

Image (chem structure or protein)

Diethylcarbamazine structure rendering